Big Pharma markets left on a ‘patent cliff’-hanger

Big Pharma markets left on a ‘patent cliff’-h...

Up next

JPMorgan walks into another football firestorm

Amazon reported accelerated cloud growth in the quarter to the end of June, and JPMorgan has walked into another football firestorm as it works on a plan with Fifa. Plus, Citadel bought Situational Awareness equity holdings after the hedge fund suffered steep AI losses, and DR Co ...  Show more

Fed holds rates as inflation fears grow

Meta and Microsoft reported quarterly earnings as investors raised concerns about AI spending, and the US Federal Reserve held interest rates steady. The Bank of Japan is also expected to leave rates unchanged at its meeting on Friday, and UK oil and gas companies are looking awa ...  Show more

Recommended Episodes

Tight-lipped but Turbo Torrent Guns For Cipla
The Morning Brief

India could soon see its largest-ever pharma deal as the 10th biggest pharma company by revenues -- Torrent -- is trying to buy the fourth largest one -- Cipla. But, is the bullet too big to bite for Torrent? Is the funding feasible? Will the compatibility not of portfolio but ...

  Show more

Can the market digest its multiple mega IPOs?
The Morning Brief

India's primary market is set to witness back-to-back billion-dollar IPOs, including Hyundai's record-breaking Rs 25,000 crore issue. With heavyweights like Swiggy and Afcons Infrastructure also preparing to go public, investors are closely watching the potential market impact. W ...  Show more

ZEE-Sony: $10 bn Climax Countdown
The Morning Brief

Zee's diverse content and Sony's global muscle promised a Bollywood blockbuster of a merger. But the highly romanticised story takes a dramatic turn! Rumours are swirling that the $10 billion mega-merger might be off. What are the hurdles? And what went wrong in the two years? ...

  Show more

Ep. 217: Discovery Debacle At Arnold & Porter
Law360's Pro Say - News & Analysis on Law and the Legal Industry

Endo Pharmaceuticals and its attorneys at Arnold & Porter are facing accusations of serious discovery misconduct during opioid litigation across the country, threatening the company with huge liability and the lawyers with reputational damage. On this week’s show, we break down t ...  Show more